Introduction
The global incidence of early-onset colorectal cancer is rising at an alarming rate, underscoring the urgent need for effective preventive and therapeutic strategies. While age-associated molecular and pathological alterations have been reported, the immunological landscape—particularly the roles of distinct T cell subtypes in anti-tumor immunity—remains poorly characterized in early-onset colorectal tumor, especially in endoscopically resected colorectal tumors.
In this study, we investigated the association between T cell subtype densities—specifically CD3+, CD4+, CD8+, and FOXP3+ T cells—and clinicopathological features, with a particular focus on tumors arising in younger individuals. Early-onset colorectal tumors were defined as those diagnosed before the age of 50, whereas later-onset tumors were defined as those diagnosed at age 50 or older.
Aims & Methods
This study aimed to evaluate the relationship between T cell subtypes and the clinicopathological features of early-onset colorectal tumors. We utilized a molecular pathology database comprising 169 cases of colorectal cancer and adenoma, analyzing a total of 306 colorectal lesions. Among these, 214 lesions were classified as early-onset tumors and had been resected via endoscopic techniques—including cold snare polypectomy, endoscopic mucosal resection, and endoscopic submucosal dissection—at Nippon Medical School Hospital in Japan between February 2017 and January 2020.
Formalin-fixed paraffin-embedded (FFPE) tissue blocks were collected, and immunohistochemical staining for CD3, CD4, CD8, and FOXP3 was conducted. The densities of CD3+, CD4+, CD8+, and FOXP3+ cells were quantified within tumor, stromal, and normal tissue regions. Depending on lesion size, one to five fields of view (median: five) were selected and imaged at 200x magnification using a BZX800 fluorescence microscope (KEYENCE). Automated image analysis was employed to determine the average number of each T cell subtype. Quantification within stromal and normal regions was restricted to specimens with sufficiently large resected tissue to include these areas in addition to tumor tissue. Clinicopathological variables were assessed retrospectively. Statistical analyses included the chi-square test for categorical variables, Spearman’s rank correlation for assessing associations, the Mann–Whitney U test for comparison of continuous variables, and the Kruskal–Wallis test for comparisons across three or more groups.
Results
Tumor locations were distributed as follows: 126 cases (41%) in the proximal colon, 142 cases (47%) in the distal colon, and 37 cases (12%) in the rectum. Compared with later-onset colorectal tumors, early-onset tumors had significantly lower numbers of CD3+, CD4+, and CD8+ T cells (all P <0.001). In contrast, no significant difference was observed in the number of FOXP3+ T cells between the two groups.
Additionally, the densities of CD3+, CD4+, and CD8+ T cells decreased with increasing tumor diameter (all P <0.001). The distributions of CD3+, CD8+, and FOXP3+ T cells also differed significantly by tumor location (P = 0.040, 0.006, and 0.013, respectively).
Conclusion
Analysis of endoscopically resected specimens suggests that anti-tumor immune responses mediated by T cells may vary depending on age of onset, tumor size, and tumor location. These findings highlight the need for further research to identify subsets of early-onset colorectal tumors that may require more intensive surveillance following endoscopic resection, based on their immunological profiles.